SATURDAY, 1st OCTOBER

OVERWHELMING INFLAMMATORY DISEASES

SEPSIS, EXTRACORPOREAL THERAPIES AND CLINICAL EVIDENCE
CLINICAL EXPERIENCE

Chairs: A. Giarratano; A. Pesenti

Extracorporeal Therapies and Antibiotics Management
F. Aucella

The Pediatric experience and the CytoPed Study
G. Bottari

What our 400 patients tell us
M. Pieri; A. M. Scandroglio

EVIDENCE IN SEPSIS: ARE WE LOOKING FOR THE PHILOSOPHER STONE?

Chairs: M. Ranieri; C. Ronco

Introductory Lecture
J. L. Vincent

Dispute
Are Extracorporeal Therapies useful for
septic patients?

Cons L. Gattinoni

Pros C. Ince

Discussion

POSTER DISCUSSION

Chairs: F. Aucella; L. Gottin

LIVER FAILURE AND EXTRACORPOREAL THERAPIES

Chairs: F. Fabretti; S. Faenza

Lecture: Extracorporeal Purification and Liver
S. Mitzner

Extracorporeal therapies face to face
I. Riva

The Biliver Study
A. Siniscalchi

Discussion

OVERWHELMING INFLAMMATORY DISEASES: THE DIAGNOSIS

Chairs: G. Berlot; A. Donati

Lecture: Biomarkers dream or reality?
P. Caironi

PSP and the diagnosis of sepsis
J. Pereira

PSP and diagnosis in Covid 19
G. Castellano

Discussion

CONCLUSION